ProQR Therapeutics N.V. (PRQR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

DARWINWEG 24 LEIDEN, NETHERLANDS 2333CR

ProQR Therapeutics NV operates as a biotechnology company. The Company focuses on developments of drugs to treat genetic disorders. ProQR Therapeutics serves customers worldwide.

Data based on most recent fiscal year report
Market Cap418.164 Million Shares Outstanding49.37 Million Avg Volume307.891 Thousand
1-Yr BETA vs S&P TR0.97 Current Ratio13.28 Quick Ratio13.28
View SEC Filings from PRQR instead.

Funds Holding PRQR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRQR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments